GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.
Immunisation rates among Australian children has risen significantly over the years. However, there remains a distinct disparity between children from Aboriginal and Torres Strait Islander communities and other Australians.
Patients & consumers
Over 1.4 million Australians are living with Chronic Obstructive Pulmonary Disease, or COPD, with as many as one in 20 people over the age of 55 affected by the condition. Although understanding of COPD has improved significantly in recent years, we are constantly seeking new avenues to explore in our relentless pursuit for better breathing.